Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 222,503 | 286,326 | 28,003 | 31,340 | 142,086 |
| Marketable Securities | 57,812 | 0 | 123,716 | 125,201 | 89,734 |
| Receivables | 78,286 | 67,968 | 23,994 | 3,267 | N/A |
| Inventories | 22,403 | 22,312 | 5,565 | 1,513 | N/A |
| TOTAL | $392,788 | $387,541 | $190,225 | $166,592 | $236,350 |
| Non-Current Assets | |||||
| PPE Net | 1,139 | 706 | 914 | 981 | 1,293 |
| Investments And Advances | 12,526 | 0 | 0 | 4,983 | 0 |
| Intangibles | 249,819 | 252,925 | 58,954 | 18,740 | 0 |
| Other Non-Current Assets | 14,482 | 5,449 | 102,813 | 103,355 | 3,221 |
| TOTAL | $277,966 | $259,080 | $162,681 | $128,059 | $4,514 |
| Total Assets | $670,754 | $646,621 | $352,906 | $294,651 | $240,864 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,618 | 7,416 | 8,690 | 9,166 | 3,151 |
| Accrued Expenses | 110,224 | 78,544 | 54,018 | 30,723 | 13,411 |
| Other current liabilities | N/A | N/A | 1,090 | 1,996 | 1,264 |
| TOTAL | $126,551 | $87,064 | $64,729 | $42,596 | $18,462 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 318,563 | 310,887 | 146,140 | 131,843 | 50,307 |
| TOTAL | $318,563 | $310,887 | $146,140 | $131,843 | $50,307 |
| Total Liabilities | $445,114 | $397,951 | $210,869 | $174,439 | $68,769 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,014 | 47,003 | 37,951 | 31,730 | 30,420 |
| Common Shares | 5 | 5 | 4 | 3 | 3 |
| Retained earnings | -644,181 | -556,239 | -392,824 | -257,159 | -173,171 |
| Other shareholders' equity | -373 | 1,644 | -217 | -35 | 83 |
| TOTAL | $225,640 | $248,670 | $142,037 | $120,212 | $172,095 |
| Total Liabilities And Equity | $670,754 | $646,621 | $352,906 | $294,651 | $240,864 |